Trials / Sponsors / SPH-BIOCAD (HK) Limited
SPH-BIOCAD (HK) Limited
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous I Healthy Adult Participants | Phase 1 | 2026-05-06 |
| Completed | To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis Plaque Psoriasis | Phase 3 | 2024-07-30 |
| Completed | Evaluate the Efficacy, Safety, and Pharmacokinetic Profile and Immunogenicity of Subcutaneous Netakimab in Chi Ankylosing Spondylitis | Phase 3 | 2023-03-20 |